Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Cytokine/chemokine dysregulation in progressive MS patient is apparent and can be modulated by calpain inhibition.

Polcyn R, Capone M, Matzelle D, Lueking B, Walker A, Kau E, Haque A, Banik N.

Metab Brain Dis. 2019 Dec 18. doi: 10.1007/s11011-019-00521-1. [Epub ahead of print]

PMID:
31853829
2.

A Missing Link between Neuron Specific Enolase Release and Poor Prognosis in Aging Patients with B-cell Lymphoma.

Polcyn R, God J, Capone M, Matzelle D, Banik NL, Haque A.

J Clin Cell Immunol. 2018;9(3). pii: e121. doi: 10.4172/2155-9899.1000e121. Epub 2018 May 15. No abstract available.

3.

Distinct Cytokine and Chemokine Expression in Plasma and Calpeptin-Treated PBMCs of a Relapsing-Remitting Multiple Sclerosis Patient: A Case Report.

Chandran R, Capone M, Matzelle D, Polcyn R, Kau E, Haque A, Banik NL.

Neurochem Res. 2018 Dec;43(12):2224-2231. doi: 10.1007/s11064-018-2655-z. Epub 2018 Oct 5.

PMID:
30291537
4.

New Insights into the Role of Neuron-Specific Enolase in Neuro-Inflammation, Neurodegeneration, and Neuroprotection.

Haque A, Polcyn R, Matzelle D, Banik NL.

Brain Sci. 2018 Feb 18;8(2). pii: E33. doi: 10.3390/brainsci8020033. Review.

5.

Neuron specific enolase is a potential target for regulating neuronal cell survival and death: implications in neurodegeneration and regeneration.

Polcyn R, Capone M, Hossain A, Matzelle D, Banik NL, Haque A.

Neuroimmunol Neuroinflamm. 2017;4:254-257. doi: 10.20517/2347-8659.2017.59. Epub 2017 Dec 6. No abstract available.

6.

Enolase and Acute Spinal Cord Injury.

Polcyn R, Capone M, Hossain A, Matzelle D, Banik NL, Haque A.

J Clin Cell Immunol. 2017;8(6). pii: 536. doi: 10.4172/2155-9899.1000536. Epub 2017 Dec 29. No abstract available.

7.

Targeting Enolase in Reducing Secondary Damage in Acute Spinal Cord Injury in Rats.

Haque A, Capone M, Matzelle D, Cox A, Banik NL.

Neurochem Res. 2017 Oct;42(10):2777-2787. doi: 10.1007/s11064-017-2291-z. Epub 2017 May 15.

8.

Administration of low dose estrogen attenuates persistent inflammation, promotes angiogenesis, and improves locomotor function following chronic spinal cord injury in rats.

Samantaray S, Das A, Matzelle DC, Yu SP, Wei L, Varma A, Ray SK, Banik NL.

J Neurochem. 2016 May;137(4):604-17. doi: 10.1111/jnc.13610. Epub 2016 Apr 12.

9.

Administration of low dose estrogen attenuates gliosis and protects neurons in acute spinal cord injury in rats.

Samantaray S, Das A, Matzelle DC, Yu SP, Wei L, Varma A, Ray SK, Banik NL.

J Neurochem. 2016 Mar;136(5):1064-73. doi: 10.1111/jnc.13464. Epub 2016 Jan 26.

10.

Calpain inhibitor attenuated optic nerve damage in acute optic neuritis in rats.

Das A, Guyton MK, Smith A, Wallace G 4th, McDowell ML, Matzelle DD, Ray SK, Banik NL.

J Neurochem. 2013 Jan;124(1):133-46. doi: 10.1111/jnc.12064. Epub 2012 Nov 22.

11.

Low dose estrogen prevents neuronal degeneration and microglial reactivity in an acute model of spinal cord injury: effect of dosing, route of administration, and therapy delay.

Samantaray S, Smith JA, Das A, Matzelle DD, Varma AK, Ray SK, Banik NL.

Neurochem Res. 2011 Oct;36(10):1809-16. doi: 10.1007/s11064-011-0498-y. Epub 2011 May 25.

12.

Inhibition of cysteine proteases in acute and chronic spinal cord injury.

Ray SK, Samantaray S, Smith JA, Matzelle DD, Das A, Banik NL.

Neurotherapeutics. 2011 Apr;8(2):180-6. doi: 10.1007/s13311-011-0037-1. Review.

13.

Neuroprotective efficacy of estrogen in experimental spinal cord injury in rats.

Samantaray S, Sribnick EA, Das A, Thakore NP, Matzelle D, Yu SP, Ray SK, Wei L, Banik NL.

Ann N Y Acad Sci. 2010 Jun;1199:90-4. doi: 10.1111/j.1749-6632.2009.05357.x. Review.

14.

Physiological low dose of estrogen-protected neurons in experimental spinal cord injury.

Samantaray S, Matzelle DD, Ray SK, Banik NL.

Ann N Y Acad Sci. 2010 Jun;1199:86-9. doi: 10.1111/j.1749-6632.2009.05360.x. Review.

15.

Postinjury estrogen treatment of chronic spinal cord injury improves locomotor function in rats.

Sribnick EA, Samantaray S, Das A, Smith J, Matzelle DD, Ray SK, Banik NL.

J Neurosci Res. 2010 Jun;88(8):1738-50. doi: 10.1002/jnr.22337.

16.

Therapeutic potential of melatonin in traumatic central nervous system injury.

Samantaray S, Das A, Thakore NP, Matzelle DD, Reiter RJ, Ray SK, Banik NL.

J Pineal Res. 2009 Sep;47(2):134-42. doi: 10.1111/j.1600-079X.2009.00703.x. Epub 2009 Jul 13. Review.

PMID:
19627458
17.
18.

Melatonin attenuates calpain upregulation, axonal damage and neuronal death in spinal cord injury in rats.

Samantaray S, Sribnick EA, Das A, Knaryan VH, Matzelle DD, Yallapragada AV, Reiter RJ, Ray SK, Banik NL.

J Pineal Res. 2008 May;44(4):348-57. Epub 2007 Dec 13.

19.

Direct evidence for calpain involvement in apoptotic death of neurons in spinal cord injury in rats and neuroprotection with calpain inhibitor.

Sribnick EA, Matzelle DD, Banik NL, Ray SK.

Neurochem Res. 2007 Dec;32(12):2210-6. Epub 2007 Aug 4.

PMID:
17676387
20.

Upregulation of calpain correlates with increased neurodegeneration in acute experimental auto-immune encephalomyelitis.

Guyton MK, Wingrave JM, Yallapragada AV, Wilford GG, Sribnick EA, Matzelle DD, Tyor WR, Ray SK, Banik NL.

J Neurosci Res. 2005 Jul 1;81(1):53-61.

PMID:
15952172

Supplemental Content

Loading ...
Support Center